Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice is a research paper published in CHEST Journal (2020). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIEHS NIH HHS
Grant: P30 ES005022
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
American Lung Association
GlaxoSmithKline
MedImmune
Sanofi
AstraZeneca
Teva Pharmaceutical Industries
National Institutes of Health
Novartis
FWCI
2.82
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords